These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4762548)

  • 1. Rates of nonenzymatic deamidation of glutaminyl and asparaginyl residues in pentapeptides.
    Robinson AB; Scotchler JW; McKerrow JH
    J Am Chem Soc; 1973 Nov; 95(24):8156-9. PubMed ID: 4762548
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure-dependent nonenzymatic deamidation of glutaminyl and asparaginyl pentapeptides.
    Robinson NE; Robinson ZW; Robinson BR; Robinson AL; Robinson JA; Robinson ML; Robinson AB
    J Pept Res; 2004 May; 63(5):426-36. PubMed ID: 15140160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relative rates of glutamine and asparagine deamidation in glucagon fragment 22-29 under acidic conditions.
    Joshi AB; Kirsch LE
    J Pharm Sci; 2002 Nov; 91(11):2331-45. PubMed ID: 12379918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of amino acid sequence, buffers, and ionic strength on the rate and mechanism of deamidation of asparagine residues in small peptides.
    Tyler-Cross R; Schirch V
    J Biol Chem; 1991 Nov; 266(33):22549-56. PubMed ID: 1939272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of peptide conformation in the rate and mechanism of deamidation of asparaginyl residues.
    Lura R; Schirch V
    Biochemistry; 1988 Oct; 27(20):7671-7. PubMed ID: 3207697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonenzymatic deamidation of asparaginyl and glutaminyl residues in proteins.
    Wright HT
    Crit Rev Biochem Mol Biol; 1991; 26(1):1-52. PubMed ID: 1678690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution and the distribution of glutaminyl and asparaginyl residues in proteins.
    Robinson AB
    Proc Natl Acad Sci U S A; 1974 Mar; 71(3):885-8. PubMed ID: 4522799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of a histidine residue on the C-terminal side of an asparaginyl residue on the rate of deamidation using model pentapeptides.
    Goolcharran C; Stauffer LL; Cleland JL; Borchardt RT
    J Pharm Sci; 2000 Jun; 89(6):818-25. PubMed ID: 10824141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deamidation of glutaminyl and asparaginyl residues in peptides and proteins.
    Robinson AB; Rudd CJ
    Curr Top Cell Regul; 1974; 8(0):247-95. PubMed ID: 4371091
    [No Abstract]   [Full Text] [Related]  

  • 10. Deamidation of glutaminyl residues: dependence on pH, temperature, and ionic strength.
    Scotchler JW; Robinson AB
    Anal Biochem; 1974 May; 59(1):319-22. PubMed ID: 4407737
    [No Abstract]   [Full Text] [Related]  

  • 11. Deamidation of human proteins.
    Robinson NE; Robinson AB
    Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12409-13. PubMed ID: 11606750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deamidation of asparaginyl residues in proteins: a potential pathway for chemical degradation of proteins in lyophilized dosage forms.
    Patel K; Borchardt RT
    J Parenter Sci Technol; 1990; 44(6):300-1. PubMed ID: 2277316
    [No Abstract]   [Full Text] [Related]  

  • 13. Deamidation via cyclic imide in asparaginyl peptides.
    Capasso S; Mazzarella L; Sica F; Zagari A
    Pept Res; 1989; 2(2):195-200. PubMed ID: 2520758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deamidation of asparaginyl residues as a hazard in experimental protein and peptide procedures.
    McKerrow JH; Robinson AB
    Anal Biochem; 1971 Aug; 42(2):565-8. PubMed ID: 5118591
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo deamidation characterization of monoclonal antibody by LC/MS/MS.
    Huang L; Lu J; Wroblewski VJ; Beals JM; Riggin RM
    Anal Chem; 2005 Mar; 77(5):1432-9. PubMed ID: 15732928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the mechanism of aspartic acid cleavage and glutamine deamidation in the acidic degradation of glucagon.
    Joshi AB; Sawai M; Kearney WR; Kirsch LE
    J Pharm Sci; 2005 Sep; 94(9):1912-27. PubMed ID: 16052557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular clocks.
    Robinson NE; Robinson AB
    Proc Natl Acad Sci U S A; 2001 Jan; 98(3):944-9. PubMed ID: 11158575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled deamidation of peptides and proteins: an experimental hazard and a possible biological timer.
    Robinson AB; McKerrow JH; Cary P
    Proc Natl Acad Sci U S A; 1970 Jul; 66(3):753-7. PubMed ID: 5269237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of primary structure deamidation rates of asparaginyl and glutaminyl peptides through steric and catalytic effects.
    Robinson NE; Robinson AB
    J Pept Res; 2004 May; 63(5):437-48. PubMed ID: 15140161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of acidic N + 1 residues on asparagine deamidation rates in solution and in the solid state.
    Li B; Gorman EM; Moore KD; Williams T; Schowen RL; Topp EM; Borchardt RT
    J Pharm Sci; 2005 Mar; 94(3):666-75. PubMed ID: 15668945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.